Entrepreneurs Fund invests actively in ground-breaking life science and technology businesses to accelerate their growth and development.
Business Model:
Revenue: $13M
Employees: 2-10
Address: 81 Fulham Road
City: Greater London
State: england
Zip: SW3 6RD
Country: GB
Entrepreneurs Fund provides early stage and growth financing alongside active support to entrepreneurial teams. Their current areas of investment focus are Life-sciences, Water, Materials and Automotive Technology.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2014 | OptiNose | Series C | 0 |
6/2013 | Vasopharm | Series F | 0 |
11/2011 | CYTOO | Series C | 10M |
10/2005 | iPolicy Networks | Series B | 0 |
10/2015 | Sequana Medical | Series C | 0 |
10/2011 | Exosect | Venture Round | 1.3M |
1/2015 | Exosect | Venture Round | 0 |
5/2011 | General Fusion | Series B | 0 |
4/2014 | Sequana Medical | Series C | 26.1M |
4/2015 | D3O | Venture Round | 0 |
5/2017 | OptiNose | Series D | 0 |
11/2006 | iPolicy Networks | Venture Round | 0 |
8/2009 | General Fusion | Series A | 13.8M |
5/2013 | Exosect | Venture Round | 3.8M |
7/2013 | General Fusion | Series C | - |
12/2009 | Exosect | Venture Round | 0 |
11/2008 | Exosect | Venture Round | 2.8M |
3/2013 | Realeyes | Series A | 3.2M |
7/2009 | Inge Watertechnologies | Venture Round | 7M |
3/2011 | Sequana Medical | Series B | 25.5M |
5/2012 | Prosonix | Series B | 0 |
1/2016 | Vasopharm | Series G | 0 |
10/2014 | Rakuten Fits Me | Venture Round | 0 |
7/2004 | Mblox | Series B | 10M |
6/2019 | Realeyes | Series B | 0 |
5/2015 | General Fusion | Venture Round | 0 |
7/2011 | Prosonix | Series B | 0 |
6/2013 | NewMotion | Series C | 0 |
1/2012 | NewMotion | Series B | 0 |
7/2006 | t2cure | Series A | - |
3/2014 | Xeros | Post-IPO Equity | 49.5M |
11/2010 | Xeros | Venture Round | 5.6M |
3/2013 | Xeros | Venture Round | 0 |
4/2013 | Rakuten Fits Me | Series A | 0 |
12/2011 | SOASTA | Venture Round | 0 |
9/2008 | VAIREX international | Series A | 7.4M |
12/2010 | Accept Software | Series C | 0 |
12/2009 | Evolva | Post-IPO Equity | 27.5M |
2/2008 | Exosect | Venture Round | 6.5M |
12/2019 | General Fusion | Series E | 0 |
11/2012 | Exosect | Venture Round | - |
8/2014 | SmartKem | Series A | 4M |
12/2019 | General Fusion | Series E | 0 |
6/2019 | Realeyes | Series B | 0 |
5/2017 | OptiNose | Series D | 0 |
1/2016 | Vasopharm | Series G | 0 |
10/2015 | Sequana Medical | Series C | 0 |
5/2015 | General Fusion | Venture Round | 0 |
4/2015 | D3O | Venture Round | 0 |
1/2015 | Exosect | Venture Round | 0 |
10/2014 | Rakuten Fits Me | Venture Round | 0 |
8/2014 | SmartKem | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|